Tumor type | dMMR/MSI (%) | References |
---|---|---|
CRC | 19 | [21] |
17 | ||
15 | [25] | |
8 | [245] | |
6 | [2] | |
EC | 33 | [246] |
30 | [21] | |
28 | [244] | |
17 | [2] | |
GC | 22 | [247] |
21 | [244] | |
15 | [25] | |
8 | [2] | |
OC | 12 | [25] |
10 | [248] | |
2–3 | ||
Cervical cancer | 2–10 | [24] |
2–3 | ||
Prostate cancer | < 2% | [24] |
1–2 | ||
HCC | 16 | [249] |
2–3 | ||
PC | 1–2 | |
GBM | 1 | |
HNSCC | 1 | |
RCC | 2 | [250] |
1–2 | ||
UTUC | 28.1 | [251] |
Lung adenocarcinoma | < 1 | |
0 | [244] | |
Lung squamous cell cancer | 1 | |
Cholangiocarcinoma | 2 | [2] |
Rectal cancer | 9 | [244] |
3 | [21] | |
Ampullary carcinoma | 10 | [252] |
Thyroid cancer | 2 | [2] |
UCEC | 17–31.37 | [29] |
ACC | 4.35 | [29] |
ESCA | 1.63 | [29] |
SKCM | 1 | [202] |
0–0.64 | [29] |